Literature DB >> 10666388

Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.

Y Takano1, Y Kato, P J van Diest, M Masuda, H Mitomi, I Okayasu.   

Abstract

G1 cyclins and cyclin-dependent kinase (CDK) complexes play important roles in G1 cell cycle transition, and their overexpression is implicated for neoplasia. The p27 protein (p27) negatively regulates G1 progression by binding to G1 cyclins/CDK complexes and inhibits their activity, resulting in inhibition of entry to the cell cycle. We investigated overexpression of cyclin D1 (CCND1), cyclin D2 (CCND2), cyclin E (CCNE), CDK2, and CDK4, in addition to p27, in 260 gastric cancer cases on the basis of Western blots, reverse transcriptase-polymerase chain reaction Southern blots, and immunohistochemistry to clarify the roles of these proteins in tumor progression and prognosis. Examination of 20 cases of fresh cancer and matched normal tissues demonstrated a clear tendency for increased mRNA synthesis to be more frequent than expected from protein levels, and a direct correlation between p27 protein and mRNA was not found. Immunohistochemistry demonstrated 21. 5%, 34.2%, 30.4%, 44.2%, and 48.0% positivity for CCND1, CCND2, CCNE, CDK2, and CDK4, respectively, in the 260 gastric cancer cases. Overexpression of CCND2 and CDK4 significantly correlated with tumor progression. Moreover, CCND2 cytoplasmic staining (26.2%) appeared to be strictly linked with progression, whereas nuclear staining (7. 8%) demonstrated an inverse correlation. Survival curves showed CCND2 (especially cytoplasmic staining) and CDK4 positivity to be associated with a poor prognosis and CCNE positivity with a better prognosis. Tumors with high p27 labeling indices (LIs) were well differentiated, with low levels of invasion and lymph node metastasis. p27-negative cases (37.3%) demonstrated a poor prognosis. Multivariate analysis revealed positivity for CCND2 and negativity for p27 to be independent prognostic factors. There were no direct links among CCND2, CCNE, CDK4, and p27. The results indicate that CCND2 cytoplasmic localization might reflect an important physiological role in tumor progression, whereas CCNE overexpression correlates with differentiation and a good prognosis, possibly because of accumulation of inactive forms of CCNE-CDK2 complexes. Loss of p27 caused by degradation activity may affect tumor cell growth in the presence of an altered extracellular matrix, facilitating metastasis. Cell-cycle-regulatory proteins appear to work independently.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666388      PMCID: PMC1850035          DOI: 10.1016/S0002-9440(10)64763-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.

Authors:  P J van Diest; R J Michalides; L Jannink; P van der Valk; H L Peterse; J S de Jong; C J Meijer; J P Baak
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  p27 expression and gastric carcinoma.

Authors:  M Mori; K Mimori; T Shiraishi; S Tanaka; H Ueo; K Sugimachi; T Akiyoshi
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

3.  Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

Authors:  S Gansauge; F Gansauge; M Ramadani; H Stobbe; B Rau; N Harada; H G Beger
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

4.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.

Authors:  P L Porter; K E Malone; P J Heagerty; G M Alexander; L A Gatti; E J Firpo; J R Daling; J M Roberts
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

6.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Authors:  C Catzavelos; N Bhattacharya; Y C Ung; J A Wilson; L Roncari; C Sandhu; P Shaw; H Yeger; I Morava-Protzner; L Kapusta; E Franssen; K I Pritchard; J M Slingerland
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

7.  Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

Authors:  M Sánchez-Beato; A I Sáez; J C Martínez-Montero; M Sol Mateo; L Sánchez-Verde; R Villuendas; G Troncone; M A Piris
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

9.  Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.

Authors:  T Zhang; L B Nanney; C Luongo; L Lamps; K J Heppner; R N DuBois; R D Beauchamp
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

Review 10.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

View more
  48 in total

1.  Positive expression of E-cadherin suppresses cell adhesion to fibronectin via reduction of alpha5beta1 integrin in human breast carcinoma cells.

Authors:  Heng Wu; Yu-Long Liang; Zengxia Li; Jiawei Jin; Wen Zhang; Lingling Duan; Xiliang Zha
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-05       Impact factor: 4.553

2.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.

Authors:  Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Xiaomin Luo; Wenling Zhang; Xiaoling Li; Songqing Fan; Li Cao; Ke Tang; Minghua Wu; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

3.  Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.

Authors:  Xiaofei Chen; Liang Liu; Jade Mims; Elizabeth C Punska; Kristin E Williams; Weiling Zhao; Kathleen F Arcaro; Allen W Tsang; Xiaobo Zhou; Cristina M Furdui
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.

Authors:  Rui Henrique; Vera Lúcia Costa; Nuno Cerveira; André Lopes Carvalho; Mohammad Obaidul Hoque; Franclim Ricardo Ribeiro; Jorge Oliveira; Manuel Rodrigues Teixeira; David Sidransky; Carmen Jerónimo
Journal:  J Mol Med (Berl)       Date:  2006-09-22       Impact factor: 4.599

Review 5.  Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.

Authors:  Sameh Mikhail; Christopher Albanese; Michael J Pishvaian
Journal:  Am J Pathol       Date:  2015-03-05       Impact factor: 4.307

6.  Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?

Authors:  Gregory Kouraklis; Iraklis E Katsoulis; Stamatios Theocharis; Gerasimos Tsourouflis; Nikos Xipolitas; Andromahi Glinavou; Chrysa Sioka; Alkiviadis Kostakis
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

7.  MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

Authors:  Qingchuan Dong; Ping Meng; Tao Wang; Weiwei Qin; Weijun Qin; Fuli Wang; Jianlin Yuan; Zhinan Chen; Angang Yang; He Wang
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  S-phase delay in human hepatocellular carcinoma cells induced by overexpression of integrin beta1.

Authors:  Yu-Long Liang; Ting-Wen Lei; Heng Wu; Jian-Min Su; Li-Ying Wang; Qun-Ying Lei; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.

Authors:  Armando Gamboa-Dominguez; Stefan Seidl; Edgardo Reyes-Gutierrez; Christine Hermannstädter; Leticia Quintanilla-Martinez; Raymonde Busch; Heinz Höfler; Falko Fend; Birgit Luber
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

10.  Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.

Authors:  Etsuo Susaki; Keiko Nakayama; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.